Updated time: 2021-10-22 18:28:30
06A-1071105
TW I607091、US 10155993 B2
Disclosed herein is a method of determining whether a subject having or is at risk of developing lung cancer. The presence of the SNP locus of rs193100333, which corresponds to a mutation on YAP1 protein with a substitution of an arginine to a tryptophan at position 331, indicates the subject has or is at risk of developing lung cancer. Accordingly, also disclosed herein is a kit for facilitating the detection of the SNP locus of rs193100333.
Current methods for cancer evaluations of lung cancer are lack of precision effectiveness. A method present here has high accuracy and validity.
- Cancer prevention
- Screening for high risk population in lung cancer

Fig1. are pedigrees of the original family .

Fig2. the validation cohort, in which the probands were indicated by the arrows; shape symbols indicated gender: square for male and circle for female; +, x, and NA inside the shape symbol indicated YAP1 R331W carrier, non-carrier, and DNA not available, respectively; deceased subjects were indicated by slashes through the shape symbols; colors indicated subjects' health statuses: lung adenocarcinoma in red, newly diagnosed lung adenocarcinoma in peach, ground glass opacity (GGO) in blue, no cancer with low dose computed tomography (LDCT) confirmation in green, other cancers in purple, normal status in white, and unknown status in grey; ages were shown under the symbols; in according to the examples of the present disclosure.
LI, Ker-Chau、Chen, Hsuan-Yu、YANG, Pan-Chyr、YU, Sung-Liang、HO, Bing-Ching、CHANG, Gee-Chen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

METHOD OR KIT FOR DETERMINING LUNG CANCER DEVELOPMENT